Bloomberg: Allergan seeks white knight to top Valeant bid

Allergan (AGN +0.6%) is holding early-stage talks with Sanofi (SNY) and Johnson & Johnson (JNJ) to see if they're interested in topping Valeant's (VRX) $45.7B bid for the Botox maker, Bloomberg reports.

Sanofi and J&J are mulling their options, although it's not clear whether they are interested.

Bayer has also been contacted, but it's focusing on trying to win an auction for Merck's over-the-counter medicines operations.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs